These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17510384)

  • 21. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
    Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas.
    Zucman-Rossi J; Benhamouche S; Godard C; Boyault S; Grimber G; Balabaud C; Cunha AS; Bioulac-Sage P; Perret C
    Oncogene; 2007 Feb; 26(5):774-80. PubMed ID: 16964294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma.
    Tamori A; Nishiguchi S; Nishikawa M; Kubo S; Koh N; Hirohashi K; Shiomi S; Inoue M
    J Gastroenterol; 2004 Nov; 39(11):1063-8. PubMed ID: 15580399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.
    Katzenellenbogen M; Mizrahi L; Pappo O; Klopstock N; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Domany E; Galun E; Goldenberg D
    Mol Cancer Res; 2007 Nov; 5(11):1159-70. PubMed ID: 18025261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B virus-associated multistep hepatocarcinogenesis: a stepwise increase in allelic alterations.
    Lee JM; Wong CM; Ng IO
    Cancer Res; 2008 Jul; 68(14):5988-96. PubMed ID: 18632655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p16 promoter hypermethylation in human hepatocellular carcinoma with or without hepatitis virus infection.
    Narimatsu T; Tamori A; Koh N; Kubo S; Hirohashi K; Yano Y; Arakawa T; Otani S; Nishiguchi S
    Intervirology; 2004; 47(1):26-31. PubMed ID: 15044833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequent loss of heterozygosity at the Hcr1 (hepatocarcinogenesis resistance) locus on chromosome 10 in primary hepatocellular carcinomas from LFF1 rat strain.
    De Miglio MR; Muroni MR; Simile MM; Virdis P; Asara G; Frau M; Calvisi DF; Seddaiu MA; Pascale RM; Feo F
    Hepatology; 2001 May; 33(5):1110-7. PubMed ID: 11343238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas.
    Gao W; Kondo Y; Shen L; Shimizu Y; Sano T; Yamao K; Natsume A; Goto Y; Ito M; Murakami H; Osada H; Zhang J; Issa JP; Sekido Y
    Carcinogenesis; 2008 Oct; 29(10):1901-10. PubMed ID: 18632756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations of beta-catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis.
    Park JY; Park WS; Nam SW; Kim SY; Lee SH; Yoo NJ; Lee JY; Park CK
    Liver Int; 2005 Feb; 25(1):70-6. PubMed ID: 15698401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ser-249 TP53 and CTNNB1 mutations in circulating free DNA of Egyptian patients with hepatocellular carcinoma versus chronic liver diseases.
    Hosny G; Farahat N; Tayel H; Hainaut P
    Cancer Lett; 2008 Jun; 264(2):201-8. PubMed ID: 18313840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microsatellite instability and p53 mutations in hepatocellular carcinoma.
    Karachristos A; Liloglou T; Field JK; Deligiorgi E; Kouskouni E; Spandidos DA
    Mol Cell Biol Res Commun; 1999; 2(3):155-61. PubMed ID: 10662591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets.
    Katoh H; Ojima H; Kokubu A; Saito S; Kondo T; Kosuge T; Hosoda F; Imoto I; Inazawa J; Hirohashi S; Shibata T
    Gastroenterology; 2007 Nov; 133(5):1475-86. PubMed ID: 17983802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenomatous polyposis coli alteration in digestive endocrine tumours: correlation with nuclear translocation of beta-catenin and chromosomal instability.
    Pizzi S; Azzoni C; Tamburini E; Bottarelli L; Campanini N; D'Adda T; Fellegara G; Luong TV; Pasquali C; Rossi G; Delle Fave G; Camisa R; Bordi C; Rindi G
    Endocr Relat Cancer; 2008 Dec; 15(4):1013-24. PubMed ID: 18632876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P53 levels determine outcome during beta-catenin tumor initiation and metastasis in the mammary gland and male germ cells.
    Ridgeway AG; McMenamin J; Leder P
    Oncogene; 2006 Jun; 25(25):3518-27. PubMed ID: 16434961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of beta-catenin mutation by dietary exposure of auraptene, a citrus antioxidant, in N,N-diethylnitrosamine-induced hepatocellular carcinomas in rats.
    Hara A; Sakata K; Yamada Y; Kuno T; Kitaori N; Oyama T; Hirose Y; Murakami A; Tanaka T; Mori H
    Oncol Rep; 2005 Aug; 14(2):345-51. PubMed ID: 16012713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetics of hepatocellular carcinoma.
    Buendia MA
    Semin Cancer Biol; 2000 Jun; 10(3):185-200. PubMed ID: 10936068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An update on the molecular genetics of hepatocellular carcinoma.
    Suriawinata A; Xu R
    Semin Liver Dis; 2004 Feb; 24(1):77-88. PubMed ID: 15085488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma.
    Nishida N; Kudo M; Nagasaka T; Ikai I; Goel A
    Hepatology; 2012 Sep; 56(3):994-1003. PubMed ID: 22407776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ARHI, as a novel suppressor of cell growth and downregulated in human hepatocellular carcinoma, could contribute to hepatocarcinogenesis.
    Huang J; Lin Y; Li L; Qing D; Teng XM; Zhang YL; Hu X; Hu Y; Yang P; Han ZG
    Mol Carcinog; 2009 Feb; 48(2):130-40. PubMed ID: 18612997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.